These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33901218)

  • 1. Prognostic and clinicopathological significance of C-reactive protein/albumin ratio (CAR) in patients with gastric cancer: A meta-analysis.
    Yu J; Liu H; Zeng X; Zhao Y; Jiang D; Lu H; Qian J
    PLoS One; 2021; 16(4):e0250295. PubMed ID: 33901218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of the pretreatment C-reactive protein/albumin ratio in gastric cancer: A systematic review and meta-analysis.
    Yang X; Song X; Zhang L; Wu C
    Medicine (Baltimore); 2020 Mar; 99(10):e19362. PubMed ID: 32150079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of pretreatment C-reactive protein/albumin ratio in nasopharyngeal carcinoma: A meta-analysis of published literature.
    Yang X; Liu H; He M; Liu M; Zhou G; Gong P; Ma J; Wang Q; Xiong W; Ren Z; Li X; Zhang X
    Medicine (Baltimore); 2018 Jul; 97(30):e11574. PubMed ID: 30045284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role of pre-treatment C-reactive protein/albumin ratio in esophageal cancer: a meta-analysis.
    Liu Z; Shi H; Chen L
    BMC Cancer; 2019 Nov; 19(1):1161. PubMed ID: 31783812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of the C-reactive protein to albumin ratio in esophageal cancer: A systematic review and meta-analysis.
    Wang Y; Hu X; Huang Y; Xu WY; Wu YM; Li PF; Che GW
    Kaohsiung J Med Sci; 2020 Jan; 36(1):54-61. PubMed ID: 31512813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
    Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M
    BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of C-reactive protein to albumin ratio in colorectal cancer: A meta analysis.
    Wang F; Li P; Li FS
    Medicine (Baltimore); 2019 Jul; 98(29):e16064. PubMed ID: 31335668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Impact of Change in the C-Reactive Protein/Albumin Ratio in Gastric Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Maezawa Y; Hashimoto I; Hara K; Komori K; Otani K; Kazama K; Sawazaki S; Numata M; Kawahara S; Cho H; Morita J; Segami K; Tanabe M; Yukawa N; Saito A; Rino Y; Ogata T; Oshima T
    J Gastrointest Cancer; 2024 Mar; 55(1):383-390. PubMed ID: 37784000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients with Bile Duct Cancer: A Meta-Analysis.
    Dai M; Zhao X; Yu A; Zhao L; Kang Q; Yan S; Zhang X; Liu J
    Nutr Cancer; 2024; 76(10):914-926. PubMed ID: 35920450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
    Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
    Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
    [No Abstract]   [Full Text] [Related]  

  • 11. The prognostic value of C-reactive protein to albumin ratio in patients with lung cancer.
    Deng TB; Zhang J; Zhou YZ; Li WM
    Medicine (Baltimore); 2018 Dec; 97(50):e13505. PubMed ID: 30558004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis.
    Xie Q; Wang L; Zheng S
    Dose Response; 2020; 18(2):1559325820931290. PubMed ID: 32647499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of the C-reactive protein to albumin ratio in cancer: An updated meta-analysis.
    Cui X; Jia Z; Chen D; Xu C; Yang P
    Medicine (Baltimore); 2020 Apr; 99(14):e19165. PubMed ID: 32243358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of the C-reactive protein to albumin ratio in colorectal cancer: an updated systematic review and meta-analysis.
    Liao CK; Yu YL; Lin YC; Hsu YJ; Chern YJ; Chiang JM; You JF
    World J Surg Oncol; 2021 May; 19(1):139. PubMed ID: 33933070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of C-reactive protein to albumin ratio in metastatic colorectal cancer: A systematic review and meta-analysis.
    Pan Y; Lou Y; Wang L
    Medicine (Baltimore); 2021 Nov; 100(46):e27783. PubMed ID: 34797305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological and prognostic value of preoperative plasma fibrinogen in gastric cancer patients: A meta-analysis.
    Cheng F; Zeng C; Zeng L; Chen Y
    Medicine (Baltimore); 2019 Oct; 98(40):e17310. PubMed ID: 31577724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of high stanniocalcin 2 expression in solid cancers: A meta-analysis.
    Hu L; Zha Y; Kong F; Pan Y
    Medicine (Baltimore); 2019 Oct; 98(43):e17432. PubMed ID: 31651846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative C-reactive protein-to-albumin ratio and clinical outcomes after resection of colorectal liver metastases.
    Sakamoto Y; Mima K; Imai K; Miyamoto Y; Tokunaga R; Akiyama T; Daitoku N; Hiyoshi Y; Iwatsuki M; Nagai Y; Baba Y; Iwagami S; Yamashita YI; Yoshida N; Baba H
    Surg Oncol; 2020 Dec; 35():243-248. PubMed ID: 32932221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of C-reactive protein to albumin ratio in colorectal cancer patients: a meta-analysis.
    Fan Y; Xiang S; Dai Z; Zou C; Wang X; Gao Z
    Int J Colorectal Dis; 2019 Jun; 34(6):1105-1111. PubMed ID: 31016379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of the C-Reactive Protein (CRP)-Albumin-Lymphocyte (CALLY) Index as a Prognostic Indicator for Patients With Gastric Cancer.
    Nakashima K; Haruki K; Kamada T; Takahashi J; Tsunematsu M; Ohdaira H; Furukawa K; Suzuki Y; Ikegami T
    Am Surg; 2024 Nov; 90(11):2703-2709. PubMed ID: 38644521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.